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OBJECTIVES: To analyse the trends and patterns of lip,
oral and oro-pharyngeal cancer incidence in Portugal
between 1998 and 2007.
PATIENTS AND METHODS: Data on lip, oral and
oro-pharyngeal cancers was collected from the data-
bases maintained at the three main Regional Cancer
Registries of Portugal (1998–2007). The data were
analysed by gender, age and by site. Incidence rates
were age standardized by the direct method, and
joinpoint regression was used to estimate trends in
incidence.
RESULTS: During this 10-year period, a total of 9623
cases of lip, oral and oropharynx cancers were reported,
7565 (78.6%) in males and 2058 (21.4%) in females. There
was an increase in the age-standardized incidence of oral
cancers by 1.96% per year for both sexes grouped
together and an increase of 4.34% per year for the female
group. Oro-pharyngeal cancer showed an increase inci-
dence trend of 3.49% per year for both sexes grouped
together and an increase of 3.49% per year for male group
among the sites analysed. Lip cancer showed a decrease
in its incidence rate.
CONCLUSION: In view of rising trends, it is necessary to
implement policies on oral cancer control by initiating
campaigns on oral cancer awareness and screening and to
harness political measures on tobacco and alcohol con-
trol for the Portuguese population.
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Introduction
Oral and pharyngeal cancers are a major public health
problem worldwide (1). The most recent estimated incidence
of oral and pharyngeal cancer (excluding nasopharynx) in
the world is around 399 600 new cases in 2008, being the
sixth most common cancer (2). However, the incidence of
this cancer varies worldwide (approximately 20-fold)
reﬂecting variations in the prevalence of speciﬁc risk factors
within the regions (3). The areas characterized by high
incidence rates for oral and oro-pharyngeal cancer are found
in the Paciﬁc regions (e.g. Papua New Guinea and other
paciﬁc islands in Melanesia), South and Southeast of Asia
(e.g. Taiwan, Maldives, Bangladesh, Sri Lanka, Pakistan,
Brunei and India), some parts of Europe (e.g. Hungary,
Luxembourg, Slovakia, France and particularly lip cancer in
Spain), and parts of Latin America and the Caribbean (e.g.
Puerto Rico, Cuba, Brazil, Dominican Republic and
Uruguay (2). In some high-risk countries such as Sri Lanka,
India, Pakistan and Bangladesh, oral cancer is the most
common cancer in men and may contribute up to 25% of all
new cases of cancer (1). Smoking, alcohol use, smokeless
tobacco products and human papillomavirus (HPV) infec-
tion are the major risk factors, with an attributable risk of
80% for both tobacco and alcohol (4).
In Portugal, the estimated incidence of oral and pharyn-
geal cancer for 2008 (excluding nasopharynx) was 1468
new cases, being the sixth most common cancer in males
with 1194 new cases and the sixteenth in females with 274
new cases per year (2).
Variations in the trends of occurrence of oral and
pharyngeal cancers have been reported internationally. In
some industrialized countries (e.g. Denmark, Netherlands,
Japan, England and Scotland), a rising incidence has been
observed in the last decades, while there has been a decline in
other countries such as Sri Lanka, Thailand or Spain (5–7).
In Portugal, a detailed comparative analysis of trends in oral
and oropharyngeal cancer has not been performed.
The aim of the present work is to analyse the trends and
patterns of lip, oral cavity and oro-pharyngeal cancer
incidence in Portugal between 1998 and 2007.
Correspondence: Luís Silva Monteiro, PhD, MSc, DDS, Department of
Medicine and Oral Surgery, Centro de Investigação em Ciências da
Saúde (CICS), Instituto Superior de Ciências da Saúde – Norte, Rua
Central de Gandra, 1317, 4585-116 Gandra PRD, Portugal. Tel:
+351919120226, Fax: +351224157102, E-mail: lmonteiro_md@hotmail.
com
Accepted for publication August 28, 2012
doi: 10.1111/jop.12010
J Oral Pathol Med (2013) 42: 345–351
© 2012 John Wiley & Sons A/S. All rights reserved
wileyonlinelibrary.com/journal/jop
Material and methods
Information was collected from the databases maintained at
the three main Regional Cancer Registries of Portugal
(RORENO, ROR-Centro and ROR-Sul). All new malignant
lip, oral cavity and oropharynx malignant neoplasms,
diagnosed between 1 January 1998 and 31 December
2007, occurring in men and women of any age, resident in
mainland Portugal or Madeira archipelago, were considered
for our analysis. During the study period (1998–2007), two
different revisions of the International Classiﬁcation of the
Diseases (ICD) were used. As differences between the two
classiﬁcations were minor, we recoded all cases according
to the 10th revision of the ICD (8). The cancers considered
in this study were lip (C00), oral cavity, which includes
tongue (C01 and C02), gum (C03), ﬂoor of the mouth
(C04), palate and other unspeciﬁed parts of the mouth (C05
and C06). Cancers of tonsils and oropharynx and other ill-
deﬁned sites and pharynx were grouped in oropharynx
cancers (C09, C10 and C14). Malignant neoplasms of
salivary glands (C07–08), nasopharynx and hypopharynx
(C11–13) were not considered in this analysis.
The incidence rates were age standardized to the Euro-
pean Standard Population by the direct method and standard
errors obtained according to the method described by Boyle
and Parkin (9). Joinpoint regression was used to estimate
trends in incidence and possibly detect inﬂexion points (10).
Results
A total of 9623 cases of lip, oral and oropharynx cancers
were reported between 1998 and 2007, 7565 (78.6%) in
males and 2058 (21.4%) in females, with a M:F ratio of
3.7:1. Squamous cell carcinomas were the most frequent
histological type reported (87.1%).
A difference in number and crude incidence rates
between sex distribution for all lip, oral cavity and oro-
pharyngeal cancers is clearly observed (Table 1) being 3–4
times higher in males than females. This ratio is maintained
over the group of cancers studied, being higher in oro-
pharyngeal cancers (5–13 times higher in men) and slightly
lower in lip cancers (2–3 times higher in men; Table 1).
Lip, oral cavity and oro-pharyngeal cancers were more
common in adults over 45 years of age (Table 2) repre-
senting 89.2% of all tumours in 2007. The highest incidence
was observed in the age group above 75 years of age for
both sexes together and the female group individually,
although in males the age group of 60–64 years was the
most affected (Fig. 1).
The speciﬁc location with highest incidence out of all oral
sites was the tongue (Fig. 2). Oro-pharyngeal cancer was
the second leading cancer out of all cancers studied. Lip
cancer had the second highest incidence in the initial year of
the study but in 2007 occupies the fourth position after
palate, and unspeciﬁed sites (C05 and C06).
When lip, oral cavity and oro-pharyngeal cancers were
considered together the trend analysis of age-standardized
incidence rates using joinpoint regression showed an
increasing trend since 2005 for both sexes grouped
together (11.19% per year since 2005; P < 0.05; Fig. 3).
The highest reported incidence was in 2007 (9.62/100 000)
and the lowest in 1999 (7.6/100 000). This trend was also
displayed in the female group with an increase of 7.58% per
year since 2003 (P < 0.05).
For the oral cavity cancers (C01–C06), there was an
increase in the age-standardized incidence of 1.96% per year
over the period studied for both sexes grouped together
(P < 0.05). The highest reported incidence was in 2007
(age-standardized rate 5.49/100 000) and the lowest in 1999
(3.96/100 000; Fig. 3). The female group showed a signif-
icant increase of 4.34% per year (P < 0.05). There was a
slight increase of this cancer in men (1.30% per year) but
without statistical signiﬁcance.
The oro-pharyngeal cancer group (C09, C10 and C14)
showed a rising trend of 3.49% per year for its incidence in
both sexes grouped together (P < 0.05) with the highest
reported incidence being in 2007 (2.79/100 000) and the
lowest in 2000 (1.88/100 000; Fig. 3). This increase was
signiﬁcant and higher in men (3.49% per year; P < 0.05).
There was an increase of this cancer in the female group
(2.02% per year) but without statistical signiﬁcance.
The incidence of lip cancer (C00) showed a signiﬁcant
decline until 2005 for both sexes with the highest reported
incidence being in 1998 (1.87/100 000) and the lowest in
2005 (0.95/100 000; Fig. 3). A reduction of 7.68% per year
was noted until 2005 (P < 0.05). This reduction was
observed in the male group (8.64% per year until 2005,
P < 0.05) as well as in the female group (3.49% per year,
P < 0.05).
Discussion
We observed a signiﬁcant increase in the incidence of oral
and oro-pharyngeal cancers over a 10-year period (1998–
2007) for both sexes in Portugal. The highest incidence was
recorded in 2007 reﬂecting ﬁrst a stable and then a rising
trend for this cancer in Portugal since 1998. This may be
related to the high tobacco and alcohol consumption in the
last decades in Portugal. Rising incidence of oral cancer in
Europe was ﬁrst reported from Denmark in late 1980 and
then from Scotland (11,12). For England and Scotland, such
rises were also conﬁrmed following a 10-year study (13).
Many European countries subsequently reported rising
trends until the end of the last century (14). Nevertheless,
more recently a decrease in oral and pharyngeal cancer
incidence in some European countries in males has been
reported. Karim–Kos et al. (7) observed an estimated
decrease in oral and pharyngeal cancer combined among
males in Ireland, France, Switzerland, Italy, Spain and
Slovenia. For females, our data are in line with the rising
trends observed in most of European countries including
Northern Europe (England, Scoland and Demark), France
and the Netherlands (7, 15).
Based on our analysis, oral cancer incidence has
increased in both sexes (1.96%/year) especially in the
female group (4.3%/year). Braakhuis et al. (16) observed an
increase of oral cancer of 0.5% and 2.0% per year for males
and females, respectively, in the Netherlands. Moreover,
some countries that reported a decrease of oral cancer in
males, showed an increase in the incidence among females.
Ligier et al. (17) reported a signiﬁcant increase in the
incidence of oral cancer in French females and a decrease in
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males. These results may be related with the different
patterns of tobacco and alcohol habits in the last decades
among men and women. Although there has been a decline
in tobacco consumption across Europe during last decades,
in women this habit has declined at a slower rate (16). On
the other hand, alcohol plays an important aetiological role
in this cancer. Although the alcohol consumption has
declined since the beginning of the last century, in 2005
Portugal was ranked the fourth country in the world with the
highest consumption of wine per capita (18). The use of
beer and distilled drinks has increased particularly in
women. The role of binge drinking, which has recently
augmented in Portugal, remains to be explored (19). Other
risk factors including socio-economic deprivation, and low
daily intake of fruit and vegetables may also contribute to
oral cancer increases (3, 20, 21). However, it is difﬁcult to
relate these with the present data in Portugal.
The results of many studies from around the world
suggest that the incidence of oral cancer is rising in young
people (13, 15, 22). Llewellyn et al. (22) ﬁrst suggest that
factors other than tobacco and alcohol may also be
implicated in the development of oral cancer in a proportion
Table 1 Incidence of lip, oral and oro-pharyngeal cancers in Portugal (1998–2007) by sex distribution
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007
All sites (C00,C01–06,C09–10,C14)
All
n 913 860 896 935 925 919 942 980 1053 1200
CR 9.21 8.62 8.94 9.25 9.09 8.97 9.15 9.48 10.16 11.56
ASR 8.21 7.60 7.89 8.05 7.79 7.61 7.72 7.92 8.49 9.62
Males
n 724 666 716 752 738 728 744 752 796 949
CR 15.16 13.86 14.81 15.41 15.02 14.71 14.95 15.05 15.89 18.91
ASR 14.58 13.21 14.01 14.41 13.83 13.45 13.58 13.62 14.31 16.87
Females
n 189 194 180 183 187 191 198 228 257 251
CR 3.68 3.76 3.47 3.50 3.56 3.61 3.73 4.28 4.81 4.69
ASR 2.76 2.74 2.62 2.52 2.57 2.54 2.62 2.87 3.31 3.22
Lip (C00)
All
n 230 197 166 162 190 156 147 138 194 200
CR 2.32 1.98 1.66 1.60 1.87 1.52 1.43 1.34 1.87 1.93
ASR 1.87 1.55 1.30 1.26 1.41 1.10 1.04 0.95 1.33 1.35
Males
n 163 146 119 116 134 113 102 85 133 146
CR 3.41 3.04 2.46 2.38 2.73 2.28 2.05 1.70 2.65 2.91
ASR 3.08 2.67 2.16 2.08 2.30 1.87 1.67 1.42 2.17 2.32
Females
n 67 51 47 46 56 43 45 53 61 54
CR 1.30 0.99 0.91 0.88 1.07 0.81 0.85 0.99 1.14 1.01
ASR 0.88 0.65 0.61 0.58 0.69 0.49 0.54 0.54 0.62 0.56
Oral Cavity (C01–C06)
All
n 467 441 526 558 510 511 541 555 585 673
CR 4.71 4.42 5.25 5.52 5.02 4.99 5.26 5.37 5.65 6.49
ASR 4.29 3.96 4.72 4.85 4.35 4.26 4.50 4.51 4.80 5.49
Males
n 380 329 412 446 411 383 429 422 423 517
CR 7.96 6.85 8.52 9.14 8.37 7.74 8.62 8.45 8.44 10.30
ASR 7.73 6.63 8.14 8.58 7.76 7.10 7.90 7.65 7.67 9.30
Females
n 87 112 114 112 99 128 112 133 162 156
CR 1.69 2.17 2.20 2.14 1.88 2.42 2.11 2.49 3.03 2.91
ASR 1.30 1.60 1.70 1.58 1.36 1.77 1.51 1.73 2.23 2.07
Oropharynx (C09–C10, C14)
All
n 216 222 204 215 225 252 254 287 274 327
CR 2.18 2.23 2.04 2.13 2.21 2.46 2.47 2.78 2.65 3.15
ASR 2.05 2.09 1.88 1.95 2.04 2.26 2.19 2.47 2.36 2.79
Males
n 181 191 185 190 193 232 213 245 240 286
CR 3.79 3.98 3.83 3.89 3.93 4.69 4.28 4.90 4.79 5.70
ASR 3.76 3.91 3.71 3.74 3.77 4.48 4.01 4.55 4.47 5.25
Females
n 35 31 19 25 32 20 41 42 34 41
CR 0.68 0.60 0.37 0.48 0.61 0.38 0.77 0.79 0.64 0.77
ASR 0.58 0.48 0.31 0.36 0.51 0.29 0.57 0.60 0.46 0.59
CR, crude rate; ASR, age-standardized rate per 100 000 population.
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of these younger patients. It has been suggested that HPV is
related with the younger presentation of oral cancer (23).
However, after the oral mucosa is infected by high-risk
HPV, it may take more than 20 years for malignant
transformation to develop. In the present work, an increase
in oral cancer among the young was not clearly evident or
different from that occurred in the older population.
Nevertheless, the percentage of oral and oro-pharyngeal
cancer in patients under 45 years of age (10.8%) is higher in
the present data than the 6% observed in many cancer
registries reported in the literature (22).
The most signiﬁcant trend in the present study was noted
in the oro-pharyngeal cancer especially in men. The rising
trend of this cancer has been noted in recent decades in
European countries including Scotland especially in men
(24), Netherlands (16), Denmark (25), and other countries
such as United Sates especially in white men (26) and, in the
British Columbia especially in men (27). This is currently
the fastest growing cancer in Scotland. Many reports
attributed this trend to HPV as the cause of this rising
incidence (27–29). Sexual behaviour and changing sex-
ual habits in the last decades may be related with
Table 2 Evolution of the number of cases and crude incidence rate by age for both sexes between 1998 and 2007
Cancer site 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007
All sites (C00, C01–C06, C09–C10, C14)
Aged below 45
n 95 110 87 121 115 103 104 120 117 117
CR 1.57 1.83 1.45 2.01 1.91 1.71 1.73 2.00 1.96 1.98
Aged above 45
n 818 750 809 814 810 816 838 860 936 1083
CR 21.08 18.98 20.21 19.92 19.51 19.38 19.61 19.83 21.29 24.32
Lip (C00)
Aged below 45
n 14 15 4 10 13 6 13 11 11 6
CR 0.23 0.25 0.07 0.17 0.22 0.10 0.22 0.18 0.18 0.10
Aged above 45
n 212 180 161 152 176 150 131 126 183 194
CR 5.46 4.56 4.02 3.72 4.24 3.56 3.06 2.90 4.16 4.36
Oral Cavity (CO1–C06)
Aged below 45
n 61 58 66 87 76 67 63 67 75 70
CR 1.01 0.96 1.10 1.44 1.26 1.11 1.05 1.12 1.26 1.18
Aged above 45
n 406 381 459 470 433 441 476 487 507 602
CR 10.46 9.64 11.47 11.50 10.43 10.47 11.14 11.23 11.53 13.52
Oropharynx (C09–C10, C14)
Aged below 45
n 20 37 17 24 26 30 28 42 31 41
CR 0.33 0.62 0.28 0.40 0.43 0.50 0.47 0.7 0.52 0.69
Aged above 45
n 196 185 187 191 199 222 226 245 243 286
CR 5.05 4.68 4.67 4.67 4.79 5.27 5.29 5.65 5.53 6.42
CR, crude rate per 100 000 population.
Figure 1 Age-speciﬁc incidence rate of lip, oral and oro-pharyngeal cancers over the period from 1998–2007 by gender distribution.
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Figure 2 Trends in age-standardized incidence rates in period of 1998–2007 by sites for both sexes.
Figure 3 Trends (1998–2007) in age standardized incidence rate for lip, oral, oro-pharyngeal and all cancers for both sexes.
Figure 4 Trends in age standardized incidence rate for lip, oral and oro-pharyngeal cancers for the period from 1998–2007 for women.
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oro-pharyngeal cancer. This probably needs further research
in Portugal to conﬁrm any associations. Prophylactic
vaccination of young people against HPV may eliminate
some oral cancers, but it may take years to reverse the trends
(29).
Lip cancer was the only cancer that showed a decrease in
its incidence rate. This was also observed by Blomberg
et al. (30) and highlights the differences in aetiological and
epidemiologic characteristics of lip cancer compared with
oral and oro-pharyngeal cancers.
The possible poor awareness of the risk factors for oral
cancer among the Portuguese population may also contribute
to the rising trend in oral and oro-pharyngeal cancers. It is
interesting to note that some high-risk countries such as Sri
Lanka, who initiated oral cancer screening campaigns some
decades ago, have recently, reported a decrease in oral cancer
incidence rates (5). It would be necessary to continue to
conduct surveillance of oral cancer data in Portugal to see
whether this rising trend continues or may show downward
trend after 2007 with more recent public health interventions.
In conclusion, our study provides evidence that the
incidence of oral and oro-pharyngeal cancers has been rising
between 1998 and 2007, in Portugal. This increasing trend
was more evident in women for oral cancer and in men for
oro-pharyngeal cancer. It is important to follow-up these
remarkable changes in the patterns of incidence of oral
cancer and to monitor these for the clues they give us to the
aetiology, so that the provision of health care for cancer can
be better planned. Furthermore, an oral health promotion
strategy should be introduced that involves elements of
basic education on oral cancer for the Portuguese popula-
tion, implementation of campaigns on oral cancer aware-
ness, appropriate screening programmes for oral cancer and
a will to engage in political measures to reduce tobacco and
alcohol use.
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